Schwartz S M, Heimark R L, Majesky M W
Department of Pathology, University of Washington School of Medicine, Seattle.
Physiol Rev. 1990 Oct;70(4):1177-209. doi: 10.1152/physrev.1990.70.4.1177.
This review tries to provide a general, and very speculative, view of growth control mechanisms that may be common to the development of blood vessels and to pathological processes including cell proliferation. From a developmental point of view, vascular growth is most likely to include local autocrine or paracrine mechanisms that permit the two cells of the vessel wall to grow, organize into the characteristic tubular and layered structures of the vessel wall, and eventually achieve a return to quiescence. The "real" mechanisms controlling growth in vivo are difficult to ascertain from studies in culture. For example, a large list of angiogenesis molecules must be able to generate endothelial replication, but in culture many of these molecules are inhibitory for each endothelial replication. Similarly, in culture, we have a long list of smooth muscle mitogens, but none of these have as of yet been proven to control smooth muscle growth in vivo. Endothelial growth control has been attributed to the presence of membrane molecules able to inhibit endothelial replication and to the actions of soluble growth factors and their receptors. Unfortunately for the former hypothesis we still lack specific molecules with the properties of contact inhibition of replication. The data discussed here, however, suggest that modulation of expression or function of cell-cell adhesive molecules could be critical both to morphogenic changes and to mitogenesis by release of cells from cell-cell contact. Moreover, our data and data from other laboratories suggest that angiogenic factors, including the HBGFs and TGF-beta, may function in angiogenesis by altering cell-cell and cell-cell substrate interactions rather than via a primary effect on cell replication. This view of angiogenesis is consistent with the absence of a mitogenic effect of some angiogenic factors. Although endothelial cell replication is obviously necessary to angiogenesis, the lack of mitogenic effect of some factors suggests a need for a more general explanation of the actions of angiogenic factors. Endothelial injury may be interrelated with smooth muscle growth. The simplest possibility is that a failure of the endothelial cell barrier function, due either to denudation or an increase in adhesivity for leukocytes, would permit access of platelets or leukocytes to the vessel wall. These extrinsic cells, in turn, would stimulate smooth muscle cell replication by release of growth factors. The second possibility is that the endothelial cell may itself release growth factors into the vessel wall.(ABSTRACT TRUNCATED AT 400 WORDS)
本综述试图对血管发育和包括细胞增殖在内的病理过程中可能共有的生长控制机制提供一个总体的、且极具推测性的观点。从发育的角度来看,血管生长很可能涉及局部自分泌或旁分泌机制,这些机制使血管壁的两种细胞得以生长,组织形成血管壁特有的管状和分层结构,并最终恢复静止状态。体内控制生长的“真正”机制很难从培养研究中确定。例如,大量的血管生成分子必须能够促使内皮细胞复制,但在培养中,许多这类分子对每个内皮细胞复制都有抑制作用。同样,在培养中,我们有一长串平滑肌有丝分裂原,但截至目前,这些分子中尚无一个被证明能在体内控制平滑肌生长。内皮细胞生长控制归因于能够抑制内皮细胞复制的膜分子的存在,以及可溶性生长因子及其受体的作用。不幸的是,对于前一种假设,我们仍然缺乏具有复制接触抑制特性的特定分子。然而,这里讨论的数据表明,细胞间黏附分子表达或功能的调节对于形态发生变化以及通过使细胞脱离细胞间接触而引发的有丝分裂可能至关重要。此外,我们的数据以及其他实验室的数据表明,包括肝素结合生长因子(HBGFs)和转化生长因子-β(TGF-beta)在内的血管生成因子,可能通过改变细胞间和细胞与细胞外基质的相互作用而非通过对细胞复制的直接作用来发挥血管生成功能。这种血管生成观点与某些血管生成因子缺乏促有丝分裂作用是一致的。虽然内皮细胞复制显然是血管生成所必需的,但某些因子缺乏促有丝分裂作用表明需要对血管生成因子的作用进行更全面的解释。内皮损伤可能与平滑肌生长相互关联。最简单的可能性是,由于剥脱或白细胞黏附性增加导致内皮细胞屏障功能失效,会使血小板或白细胞得以进入血管壁。反过来,这些外来细胞会通过释放生长因子刺激平滑肌细胞复制。第二种可能性是内皮细胞自身可能向血管壁释放生长因子。(摘要截选至400字)